Skip to main content

Table 1 Demographic data of aPC and no-aPC patients

From: The aPC treatment improves microcirculation in severe sepsis/septic shock syndrome

   aPC group (n = 13) No-aPC group (n = 9) p
Gender Male: Female 10:3 5:4 ns
Age Median (min-max) 54 (31–77) 61 (34–84) ns
APACHE II a Median (min-max) 26 (16–40) 29 (20–36) ns
28-day mortality Survivors 8 5 ns
  Non-survivors 5 4 ns
Baseline disease Trauma 5 3 ns
  COPDb 1 1 ns
  Pneumonia 2 1 ns
  Tiroidectomy 1 - ns
  Septic shock 4 2 ns
  AAAc - 1 ns
Source of sepsis Lung 5 4 ns
  Urinary tract 2 1 ns
  Abdomen 3 2 ns
  Blood 3 2 ns
Pathogen Gram - 9 7 ns
  Gram + 4 2 ns
  1. aAcute Physiology and Chronic Health Evaluation II score.
  2. bChronic Obstructive Pulmonary Disease.
  3. cAbdominal Aortic Aneurismectomy.